XML 72 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Revenue Recognition and Accounts Receivable - Schedule of Net Sales by Major Product Category by Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 184,006 $ 113,996 $ 546,226 $ 338,484
Change 61.40%   61.40%  
Bone Growth Therapies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 53,359 46,531 $ 153,735 136,244
Change 14.70%   12.80%  
Spinal Implants, Biologics, and Enabling Technologies [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 100,993 39,655 $ 307,799 123,379
Change 154.70%   149.50%  
Global Spine [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 154,352 86,186 $ 461,534 259,623
Change 79.10%   77.80%  
Global Orthopedics [Member]        
Revenue Recognition And Accounts Receivable [Line Items]        
Net sales $ 29,654 $ 27,810 $ 84,692 $ 78,861
Change 6.60%   7.40%